Document is current
Any future updates will be listed below
-
Authors
Schaub, Annalisa https://orcid.org/0000-0002-0408-5297
Erdmann, Hannes https://orcid.org/0000-0002-2620-1850
Scholz, Veronika
Timmer, Manuela
Cordts, Isabell https://orcid.org/0000-0002-2078-1997
Günther, Rene https://orcid.org/0000-0003-0329-5644
Reilich, Peter https://orcid.org/0000-0002-2464-0681
Abicht, Angela
Schöberl, Florian https://orcid.org/0000-0002-8183-8133
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 1 May 2024
Revised: 9 June 2024
Accepted: 11 June 2024
First Online: 25 June 2024
Declarations
:
: FS reports honoraria for advisory boards for Amylyx, Alnylam and Alexion. All the other authors report no competing interest.
: Informed consent was obtained from all participants. All genetic analyses and investigations were performed in accordance with the guidelines of the Declaration of Helsinki and approved by local institutions (Bayerische Landesärztekammer, vote no. 2019-210).
